Reduced renal function in hypertension in young adults: a systematic review

Objective. The aim of the systematic review was to find an answer to the question: «does an increased blood pressure affect kidney function at young age?».

Design and methods. The following key words were used to search for relevant publications: “hypertensive nephropathy”, “reduction of glomerular filtration rate in arterial hypertension” in Russian and English. We used “eLIBRARY.RU — SCIENTIFIC ELECTRONIC LIBRARY” and PubMed.gov databases. The inclusion criteria were the young age of the examined patients (from 18 to 44 years), the absence of concomitant pathology. The analysis included only publications of the last 5 years (2015-2020).

Results. A total of 18 articles were selected from Russian and international databases that meet inclusion criteria.

Conclusions. Based on the analysis of the literature of the last 5 years we assume that increase in blood pressure disrupts kidney function in young people. However, the current data a number of limitations. Until now, gender characteristics, risk factors for decreased renal function in hypertension in young people, and most importantly, the pathogenetic basis of renal dysfunction remain unclear.

1. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002;62:1402-7. doi: 10.1111/j.1523-1755.2002.kid571.

2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305. doi: 10.1056/nejmoa041031.

3. Moiseev VS, Mukhin NA, Smirnov AV, Kobalava ZhD, Bobkova IN, Villeval'de SV et al. Cardiovascular risk and chronic kidney disease: strategies for cardio-nephroprotection. Eurasian Journal of Internal Medicine. 2014;4(1):232-257. In Russian

4. Kobalava ZhD, Bobkova IN, Villevalde SV, Efremovtseva MA, Kozlovskaya LV, Shvetsov MYu et al. Cardiovascular risk and chronic kidney disease: strategies for cardio-nephroprotection. RCJ. 2014;112(8):7-37. doi: 10.15829/1560-4071-2014-8-7-37. In Russian

5. Lea JP, Greene EL, Nicholas SB, Agodoa L, Norris KC. Cardiorenal metabolic syndrome in the african diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition. Ethn Dis. 2009;19(Suppl 2):11-14.

6. McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008;51 (4 Suppl 2):38-45. doi: 10.1053/j.ajkd.2007.12.017.

7. Oshchepkova EV, Dolgusheva IuA, Zhernakova IuV, Chazova IE, Shal'nova SA, Iarovaia EB et al. The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study). Systemic Hypertension. 2015;12(3):19-24 doi:10.15829/1560-4071-2018-6-131-140. In Russian

8. Kurzin LM, Neklyudova YuA, Efimov AA, Alekseev YuD, Semina MN. Morphological assessment of structural changes in human kidneys in the age aspect // Modern problems of science and education. 2012;2:95. In Russian

9. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3.

10. Khamidova ZN, rakhmatova MR, Shajanova NS. The frequency of hypertensive nephropathy and its course in women of fertile age with arterial hypertension. Bulletin of the Council of young scientists and specialists of the Chelyabinsk region. 2016;4(5-15):54-58. In Russian

11. Gaipov A, Solak Y, Zhampeissov N, Dzholdasbekova A, Popova N, Molnar MZ et al. Renal functional reserve and renal hemodynamics in hypertensive patients. Ren Fail. 2016;8(9):1391-1397. doi: 10.1080/0886022X.2016.1214052.

12. Krutikov ES, Chistyakova SI, Tsvetkov VA. Features of intrarenal blood flow in patients with essential arterial hypertension in the preclinical stage of nephropathy. Clinical Nephrology. 2015;5(6):18-22. ISSN: 2075-3594. In Russian

13. Pereira М, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J. Hypertens. 2009;25(5):963–975. doi: 10.1097/hjh.0b013e3283282f65.

14. Chulkov VS, Vereina NK, Chulkov VS. Factors associated with kidney damage in arterial hypertension and abdominal obesity at a young age. Modern problems of science and education. 2019;1:57. doi: 10.17513/spno.28561. In Russian

15. Antropova ON, Osipova IV, Silkina SB, Markina IL, Smyshlyaeva TL, Meshkova TV. State of target organs in young people with high-normal arterial pressure and untreated essential arterial hypertension. Ateroscleroz. 2019;4(15):39-45. doi: 10.15372/ATER20190403. In Russian

16. Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A et al. The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015;386:1588–98. doi:10.1016/S0140-6736(15)00418-3.

17. Kovalkova NA, Ragino YuI, Shcherbakova LV, Khudyakova AD, Denisova DV, Voevoda MI. Interrelations of arterial hypertension and reduced renal function in the population of 25-45 years. Therapeutic archive. 2019;91(1):64-70. doi: 10.26442/00403660.2019.01.000032. In Russian

18. Okaka EI, Okwuonu CG. Blood pressure variation and its correlates among patients undergoing hemodialysis for renal failure in Benin City, Nigeria. Ann Afr Med. 2017;2(16):65-69. doi: 10.4103/aam.aam_29_16.

19. Hodel NC, Hamad A, Praehauser C, Mwangoka G, Kasella IM, Reither K et al. The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa. PLoS One. 2018;10(13):e0205326. doi: 10.1371/journal.pone.0205326.

20. Catena C, Colussi G, Martinis F, Novello M, Sechi LA. Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naïve patients with hypertension. J Hypertens. 2017;35(12):2510-2516. doi: 10.1097/HJH.0000000000001476.

21. Shulkina SG, Smirnova EN. Diagnostic value of сystatin C and collagen type IV in patients with hypertension and obesity. Arterial Hypertension. 2017;23(6):552-560. doi: 10.18705/1607-419X-2017-23-6-552-560. In Russian

22. Wali U, Hussain MM, Wali N, Nadeem A, Majeed F. Comparison of serum levels of Cystatin-C and traditional renal biomarkers for the early detection of pre-hypertensive nephropathy. J Pak Med Assoc. 2019;69(3):313-319.

23. Shulkina SG, Shchekotov VV, Smirnova EN, Antipova AA. Vasculoendothelial vascular growth factor and lipocalin 2 as markers of early nephron damage in patients with hypertension and obesity. Modern technologies in medicine. 2016;8(1):148-152. doi: 10.17691/stm2016.8.1.20. In Russian

24. Hu MC, Kuro-o M, Moe OW. Klotho and Chronic Kidney Disease. Contrib Nephrol. 2013;180:47-63. doi: 10.1159/000346778.

25. Mukhin NA, Milovanova LYu, Fomin VV, Kozlovskaya LV, Taranova MV, Androsova TV et al. Assessment of cardiovascular risk using morphogenetic protein Klotho in patients with chronic kidney disease. Clinical medicine. 2017;95(3):272-277. doi: 10.18821/0023-2149-2017-95-3-272-277. In Russian

26. Milovanova LY, Mukhin NA, Kozlovskaya LV, Milovanov YS, Kiyakbaev GG, Rogova IV et al. Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance. Vestn Ross Akad Med Nauk. 2016;71(4):288-96. Russian. doi:10.15690/vramn581.

27. Yu MY, Kim JE, Lee S, Choi JW, Kim YC, Han SS et al. Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure. Exp Cell Res. 2020;386(1):111706. doi: 10.1016/j.yexcr.2019.111706.

28. Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 2019;10(1):2145. doi: 10.1038/s41467-019-10116-0.

29. Buus NH, Mulvany MJ, Eiskjar H, Christensen KL, Skov K. Renal resistance and long-term blood pressure in individuals genetically predisposed for essential hypertension: 10-year follow-up of the Danish Hypertension Prevention Project. J Hypertens. 2016;34(6):1170-7. doi: 10.1097/HJH.0000000000000919.